INTERNATIONAL PATENT: HANSA BIOPHARMA AB FILES APPLICATION FOR "REGIMEN FOR VECTOR-BASED THERAPIES"

GENEVA, April 13 -- HANSA BIOPHARMA AB (P.O. Box 785220 07 Lund) filed a patent application (PCT/EP2025/078541) for "REGIMEN FOR VECTOR-BASED THERAPIES" on Oct 03, 2025. With publication no. WO/2026/074173, the details related to the patent application was published on Apr 09, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KJELLMAN, Christian (c/o Hansa Biopharma ABScheelevagen 22P.O. Box 785220 07 Lund), WINSTEDT, Lena (c/o Hansa Biopharma ABScheelevagen 22P.O. Box 785220 07 Lund), JARNUM, Sofia (c/o Hansa Biopharma ABScheelevagen 22P.O. Box 785220 07 Lund), BOCKERMANN, Robert (c/o Hansa B...